Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate
about
Nanoparticle-mediated drug delivery for treating melanomaNanotechnology: Future of OncotherapyDevelopment and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic CancerClinical Translation of Nanomedicine.Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery.Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsRecent trends in targeted anticancer prodrug and conjugate design.Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813.In vivo magnetic resonance imaging of tumor protease activity.Poly(ethylene oxide)-block-polyphosphester-based Paclitaxel Conjugates as a Platform for Ultra-high Paclitaxel-loaded Multifunctional Nanoparticles.Multimonth controlled small molecule release from biodegradable thin films.Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting.Polymer-drug conjugates: recent development in clinical oncologyPhysicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.Protease-activated drug development.Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenograftsFabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.The Role of Molecular Imaging in Drug Delivery.Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cellsMultifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Update on taxane development: new analogs and new formulationsA paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer modelsAdvanced materials and processing for drug delivery: the past and the future.Nanoparticle characterization: state of the art, challenges, and emerging technologies.Polymer-drug conjugates as modulators of cellular apoptosis.A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.Clinically relevant anticancer polymer Paclitaxel therapeutics.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats.Nanoparticles containing insoluble drug for cancer therapy.A novel rapamycin-polymer conjugate based on a new poly(ethylene glycol) multiblock copolymer.A cell-based pharmacokinetics assay for evaluating tubulin-binding drugsDesigning disorder: Tales of the unexpected tails.Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)- paclitaxel nanoconjugate.Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.Human mutations that confer paclitaxel resistance.Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.
P2860
Q26798379-719CEA0F-A6A6-44C4-856F-561C9A57E314Q26801067-1C965CCA-BF70-4A42-8124-0779F4A27980Q28552050-71351BE3-B761-4FF4-8468-F2A0D43BCC32Q30355939-93C19C6A-9862-4F97-86B5-CBA1883F205BQ30459975-DD62570E-AC5B-4B95-B0A6-58ABA9D4ADE8Q33279714-74AB36A9-7BA1-4FE8-A0BC-F7D692CA5396Q33380181-F608F583-00BB-480C-9532-7211A4C85DD4Q33554366-EF3D7312-2DA9-4DF4-B652-2BD972AA8946Q33573762-4EF4B86A-7ED4-46CE-B5D5-C832ADC63ACAQ33976776-A233C924-A055-4F8A-B2B1-12F81669F510Q34048774-B3B21143-132C-4D0B-84A4-9C6137A7A273Q34069122-C449C6ED-5EE2-47DB-9E69-74C82EA31272Q34082780-1F1700EA-29DE-4B34-9FB5-5FE3B6725B33Q34590348-4466D736-6669-4255-8753-65D86854ECDBQ34656003-4AD6F99F-D670-41A9-A236-2CA39FE5384DQ35488326-E05C16D5-6897-4ED2-B445-5F33EC96B837Q35811508-72C5DDE1-1878-4E4D-B5A9-66302D55AF69Q35855107-93C0B0A1-08C0-467A-8BA9-7328855FFB72Q36090300-4E1D6898-7216-4EB3-944C-B5914AC6E08DQ36108266-7C12AC88-BFB5-4659-8FC2-011BC9F18C6FQ36119847-6F6CA540-A714-40E5-93D2-A09E4B40B84CQ36214907-8082F47A-E356-4386-892A-7AA56396DA73Q36470377-3B226537-3D63-4F8E-B406-653F381C736EQ36580541-B6A958F7-B741-4A2E-B1D3-6D5FCBE12FDBQ36589333-1C92BB7A-67E2-4D2B-994C-ABA803AFC04CQ36901928-BE712079-96CC-42ED-8696-2D40045AB091Q36956674-97BAD2D9-6735-47D7-AEDC-81E248434CD0Q37114366-1E915631-54FF-46BC-A6D0-B50D888CE0C4Q37129736-446C8449-9931-40DB-ACE4-87CAAAE1D83FQ37467770-9CEFCF01-CB48-44F1-B4A4-622546E62CD1Q37594652-A8AD210E-0BA3-41DB-A759-3E59D0ABFAE6Q37693046-0A557ED2-6AA8-457E-A101-B6FDE68ABEE9Q37698614-A16DE0E8-DBED-4860-B8FA-66C10CAD9C8BQ38561970-2D216420-1BF2-4918-9C1C-8DC7F32A6636Q38779715-01531994-BB67-4CA2-A96E-A3ED15C43A90Q39637131-DE162AB2-9830-43D7-BBC7-AF848D12B96DQ39949731-01218A87-5A25-4659-9825-24372C22E4D5Q40230159-42FB36DB-EFAB-48A5-8D94-CB5131573AFFQ41769659-06714265-4EE7-438B-9476-BAC0F6A34A0FQ41897007-5906E9AE-E8DF-4913-9F95-0D11D435F941
P2860
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@ast
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@en
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@nl
type
label
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@ast
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@en
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@nl
prefLabel
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@ast
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@en
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@nl
P2093
P3181
P1433
P1476
Complete regression of well-es ...... mic acid)-paclitaxel conjugate
@en
P2093
Stephens LC
P304
P3181
P407
P577
1998-06-01T00:00:00Z